These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30391126)

  • 1. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
    Koivunen P; Serpi R; Dimova EY
    Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease.
    Laitakari A; Ollonen T; Kietzmann T; Walkinshaw G; Mennerich D; Izzi V; Haapasaari KM; Myllyharju J; Serpi R; Dimova EY; Koivunen P
    Redox Biol; 2019 Apr; 22():101145. PubMed ID: 30802717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases.
    Aitbaev KA; Murkamilov IТ; Fomin VV
    Ter Arkh; 2018 Aug; 90(8):86-94. PubMed ID: 30701951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.
    Laitakari A; Tapio J; Mäkelä KA; Herzig KH; Dengler F; Gylling H; Walkinshaw G; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    J Mol Med (Berl); 2020 May; 98(5):719-731. PubMed ID: 32296880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span.
    Laitakari A; Huttunen R; Kuvaja P; Hannuksela P; Szabo Z; Heikkilä M; Kerkelä R; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    FASEB J; 2020 Apr; 34(4):5590-5609. PubMed ID: 32100354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.
    Leinonen H; Koivisto H; Lipponen HR; Matilainen A; Salo AM; Dimova EY; Hämäläinen E; Stavén S; Miettinen P; Myllyharju J; Koivunen P; Tanila H
    Neuropharmacology; 2019 Jul; 153():63-72. PubMed ID: 31029587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles.
    Myllyharju J; Koivunen P
    Biol Chem; 2013 Apr; 394(4):435-48. PubMed ID: 23324380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of hypoxia-inducible factor prolyl 4-hydroxylase 2 in FoxD1-lineage mesenchymal cells leads to congenital truncal alopecia.
    Rosendahl AH; Monnius M; Laitala A; Railo A; Miinalainen I; Heljasvaara R; Mäki JM; Myllyharju J
    J Biol Chem; 2022 Apr; 298(4):101787. PubMed ID: 35247391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets.
    Myllyharju J
    Ann Med; 2008; 40(6):402-17. PubMed ID: 19160570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.
    Lefere S; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Devisscher L; Geerts A
    Cell Mol Life Sci; 2016 Sep; 73(18):3419-31. PubMed ID: 27091156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.
    Myllymäki MNM; Määttä J; Dimova EY; Izzi V; Väisänen T; Myllyharju J; Koivunen P; Serpi R
    Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways.
    Ullah K; Rosendahl AH; Izzi V; Bergmann U; Pihlajaniemi T; Mäki JM; Myllyharju J
    Sci Rep; 2017 Dec; 7(1):17220. PubMed ID: 29222481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Knockdown and Pharmacologic Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases.
    Pickel C; Taylor CT; Scholz CC
    Methods Mol Biol; 2018; 1742():1-14. PubMed ID: 29330785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
    Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
    Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.
    Li A; Zhang Y; Wang Z; Dong H; Fu N; Han X
    Chem Biol Interact; 2019 Apr; 303():40-49. PubMed ID: 30817904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.